{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=intravenous+fluid+treatment&page=3", "query": { "intervention": "intravenous fluid treatment", "page": 3 }, "page_size": 10 }, "pagination": { "page": 3, "page_size": 10, "total_count": 269, "total_pages": 27, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=intravenous+fluid+treatment&page=4&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=intravenous+fluid+treatment&page=2&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-08T02:39:46.645Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05403086", "title": "Pragmatic Trial of Psilocybin Therapy in Palliative Care", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Demoralization" ], "interventions": [ { "name": "Psilocybin", "type": "DRUG" }, { "name": "Ketamine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Charles S. Grob, M.D.", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 100, "start_date": "2025-01-19", "completion_date": "2027-12-31", "has_results": false, "last_update_posted_date": "2025-11-25", "last_synced_at": "2026-10-08T02:39:46.645Z", "location_count": 5, "location_summary": "Greenbrae, California • Los Angeles, California • San Francisco, California + 2 more", "locations": [ { "city": "Greenbrae", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Torrance", "state": "California" }, { "city": "Rockville", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT05403086" }, { "nct_id": "NCT06390956", "title": "Pirtobrutinib in Combination With Rituximab in Adults With Untreated Marginal Zone Lymphoma (PIONEER-MZL)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Marginal Zone Lymphoma" ], "interventions": [ { "name": "Pirtobrutinib", "type": "DRUG" }, { "name": "Rituximab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Utah", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 23, "start_date": "2025-02-20", "completion_date": "2032-12", "has_results": false, "last_update_posted_date": "2025-12-04", "last_synced_at": "2026-10-08T02:39:46.645Z", "location_count": 2, "location_summary": "St Louis, Missouri • Salt Lake City, Utah", "locations": [ { "city": "St Louis", "state": "Missouri" }, { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT06390956" }, { "nct_id": "NCT00354172", "title": "Donor Umbilical Cord Blood Natural Killer Cells, Aldesleukin and Umbilical Cord Blood Transplant in Patients With Refractory Hematologic Cancers.", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Leukemia", "Myelodysplastic Syndromes" ], "interventions": [ { "name": "aldesleukin", "type": "BIOLOGICAL" }, { "name": "filgrastim", "type": "BIOLOGICAL" }, { "name": "natural killer cell (NK) therapy", "type": "BIOLOGICAL" }, { "name": "cyclophosphamide", "type": "DRUG" }, { "name": "cyclosporine", "type": "DRUG" }, { "name": "fludarabine phosphate", "type": "DRUG" }, { "name": "methylprednisolone", "type": "DRUG" }, { "name": "mycophenolate mofetil", "type": "DRUG" }, { "name": "Umbilical Cord Blood Transplantation (UCBT)", "type": "PROCEDURE" }, { "name": "Total body irradiation (TBI)", "type": "RADIATION" } ], "intervention_types": [ "BIOLOGICAL", "DRUG", "PROCEDURE", "RADIATION" ], "sponsor": "Masonic Cancer Center, University of Minnesota", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "45 Years", "sex": "ALL", "summary": "Up to 45 Years" }, "enrollment_count": 16, "start_date": "2006-02", "completion_date": "2008-08", "has_results": true, "last_update_posted_date": "2017-12-28", "last_synced_at": "2026-10-08T02:39:46.645Z", "location_count": 1, "location_summary": "Minneapolis, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT00354172" }, { "nct_id": "NCT05098067", "title": "Capsaicin Cream as an Adjunctive Therapy for Nausea and Vomiting of Pregnancy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hyperemesis Gravidarum", "Nausea Gravidarum", "Vomiting of Pregnancy" ], "interventions": [ { "name": "Capsaicin Topical Cream", "type": "DRUG" }, { "name": "Metoclopramide", "type": "DRUG" }, { "name": "Ondansetron", "type": "DRUG" }, { "name": "Lactated Ringers, Intravenous", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Women and Infants Hospital of Rhode Island", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 30, "start_date": "2022-05-24", "completion_date": "2023-03-01", "has_results": true, "last_update_posted_date": "2024-02-07", "last_synced_at": "2026-10-08T02:39:46.645Z", "location_count": 1, "location_summary": "Providence, Rhode Island", "locations": [ { "city": "Providence", "state": "Rhode Island" } ], "official_url": "https://clinicaltrials.gov/study/NCT05098067" }, { "nct_id": "NCT05586581", "title": "SV2A & TSPO PET Imaging Measures to Reveal Mechanisms of HIV Neuropathogenesis During Antiretroviral Therapy", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "HIV Associated Neurocognitive Disorder", "HIV Dementia", "HIV Encephalitis", "Healthy" ], "interventions": [ { "name": "SV2A PET", "type": "DRUG" }, { "name": "TSPO PET", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Yale University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 70, "start_date": "2023-05-17", "completion_date": "2030-12", "has_results": false, "last_update_posted_date": "2026-08-18", "last_synced_at": "2026-10-08T02:39:46.645Z", "location_count": 1, "location_summary": "New Haven, Connecticut", "locations": [ { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT05586581" }, { "nct_id": "NCT01279603", "title": "Study of GO-203-2C Given Intravenously in Patients With Advanced Solid Tumors Including Lymphomas", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Solid Tumors" ], "interventions": [ { "name": "GO-203-2c", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Genus Oncology, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 23, "start_date": "2011-01", "completion_date": "2013-05", "has_results": false, "last_update_posted_date": "2014-09-19", "last_synced_at": "2026-10-08T02:39:46.645Z", "location_count": 4, "location_summary": "Scottsdale, Arizona • Los Angeles, California • Boston, Massachusetts + 1 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01279603" }, { "nct_id": "NCT07179003", "title": "A Phase 2 Study of Methylene Blue Photodynamic Therapy for Treatment of Breast Abscesses", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Breast Abscess" ], "interventions": [ { "name": "Standard of care breast abscess drainage", "type": "PROCEDURE" }, { "name": "Methylene Blue", "type": "DRUG" }, { "name": "Lipid Emulsion", "type": "DRUG" }, { "name": "Insertion of optical fiber", "type": "DEVICE" }, { "name": "Laser illumination", "type": "DEVICE" }, { "name": "Photodynamic therapy", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE", "DRUG", "DEVICE" ], "sponsor": "University of Rochester", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 50, "start_date": "2027-07", "completion_date": "2032-06", "has_results": false, "last_update_posted_date": "2026-08-19", "last_synced_at": "2026-10-08T02:39:46.645Z", "location_count": 1, "location_summary": "Rochester, New York", "locations": [ { "city": "Rochester", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT07179003" }, { "nct_id": "NCT00005086", "title": "Combination Chemotherapy in Treating Patients With Stage IV Locally Advanced or Metastatic Bladder Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Bladder Cancer" ], "interventions": [ { "name": "cisplatin", "type": "DRUG" }, { "name": "docetaxel", "type": "DRUG" }, { "name": "gemcitabine hydrochloride", "type": "DRUG" }, { "name": "methotrexate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Chicago", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 6, "start_date": "1999-08", "completion_date": "2005-04", "has_results": false, "last_update_posted_date": "2013-09-05", "last_synced_at": "2026-10-08T02:39:46.645Z", "location_count": 4, "location_summary": "Chicago, Illinois • Peoria, Illinois • Fort Wayne, Indiana", "locations": [ { "city": "Chicago", "state": "Illinois" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Peoria", "state": "Illinois" }, { "city": "Fort Wayne", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT00005086" }, { "nct_id": "NCT01850888", "title": "MIBG for Refractory Neuroblastoma and Pheochromocytoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Relapsed Neuroblastoma", "Metastatic Pheochromocytoma" ], "interventions": [ { "name": "131 I-Metaiodobenzylguanidine (131I-MIBG)", "type": "DRUG" }, { "name": "Potassium iodide solution", "type": "DRUG" }, { "name": "G-CSF", "type": "DRUG" }, { "name": "hematopoietic stem cell infusion", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Masonic Cancer Center, University of Minnesota", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Year", "maximum_age": null, "sex": "ALL", "summary": "1 Year and older" }, "enrollment_count": 15, "start_date": "2013-12", "completion_date": "2025-10-20", "has_results": false, "last_update_posted_date": "2025-12-18", "last_synced_at": "2026-10-08T02:39:46.645Z", "location_count": 1, "location_summary": "Minneapolis, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT01850888" }, { "nct_id": "NCT02339155", "title": "Effect of Raxibacumab on Immunogenicity of Anthrax Vaccine Adsorbed", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Infections, Bacterial" ], "interventions": [ { "name": "AVA", "type": "BIOLOGICAL" }, { "name": "Raxibacumab", "type": "BIOLOGICAL" }, { "name": "Diphenhydramine", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Emergent BioSolutions", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 573, "start_date": "2015-02-24", "completion_date": "2017-06-06", "has_results": true, "last_update_posted_date": "2024-03-18", "last_synced_at": "2026-10-08T02:39:46.645Z", "location_count": 3, "location_summary": "Edgewater, Florida • Overland Park, Kansas • Knoxville, Tennessee", "locations": [ { "city": "Edgewater", "state": "Florida" }, { "city": "Overland Park", "state": "Kansas" }, { "city": "Knoxville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT02339155" } ] }